Clinical Trial Update: Safety Study of the VEGA UV-A System to Treat Keratoconus [Phase 3]

View source ↗

Summary

A Phase 3 safety study of the VEGA UV-A System for keratoconus was terminated; results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconus

Drugs mentioned

• VEGA UV-A System

Snippet

Sponsor: Topcon Medical Systems, Inc. | Conditions: Keratoconus | Phase 3 | Status: TERMINATED | Results posted: 2013-03-04